UnitedHealth and its pharmacy benefit manager OptumRx are being sued by an independent pharmacy for allegedly strong-arming pharmacies into agreeing to “unconscionable” performance-based fees, ...

The UnitedHealthcare headquarters in Minnetonka, Minn., lowered its flags to half-staff on Wednesday, Dec. 4, 2024, in honor ...

OptumRx specializes in the delivery, clinical management and affordability of prescription medications and consumer health products. Our high-quality, integrated services deliver optimal member ...

First large-scale pharmacy care services company to implement fully sustainable packaging for temperature-sensitive prescriptions, reducing environmental impact New packaging eliminates polystyrene, ...

For years, drug prices have been on the rise, leaving as many as 18 million Americans struggling to pay for necessary prescriptions. A drug pricing provision of the Build Back Better Act, which passed ...

OptumRx has to repay the state $15 million in prescription-drug overcharges assessed to the Ohio Bureau of Workers’ Compensation (BWC) under an agreement announced today by Ohio Attorney General Dave ...

OptumRx is paying $20 million to settle allegations the company broke federal law by mailing opioids alongside other medications without resolving red flags about whether they were for legitimate ...

UnitedHealth Group's Q1 earnings highlight OptumRx's exceptional performance and its growing significance in the company's financials. OptumRx is utilizing big data analytics to unlock efficiencies, ...

UnitedHealth Group's pharmacy benefit manager OptumRx announced Monday that it will acquire Diplomat, a struggling specialty pharmacy and PBM headquartered in Flint, Mich. Diplomat provides specialty ...

UnitedHealth Group (NYSE: UNH) is the largest health insurance company in the United States with consolidated revenue of $226 billion in 2018. It provides individual insurance, employer sponsored ...

As 2023 draws to a close, pressure has been heating up on PBMs over their business practices, including from Congress, the CMS and antitrust agencies. The drug middlemen are also facing lawsuits from ...